3-n-butylphthalide has been researched along with alpha-synuclein in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, YZ; Huang, JZ; Liu, CF; Su, M; Yang, YP; Zheng, HF | 1 |
| Chen, Y; Ge, B; Jiang, M; Li, L; Wei, D; Xu, W; Ye, M; Yu, M; Zhang, L | 1 |
| Chang, Z; Huang, Z; Jin, D; Li, H; Que, R; Tan, EK; Wang, HT; Wang, Q; Xie, Z; Xu, J; Yang, W; Zhang, W; Zheng, J | 1 |
| Buzoianu, AD; Feng, L; Lafuente, JV; Muresanu, DF; Nozari, A; Sharma, A; Sharma, HS; Tian, ZR; Wang, Z; Wiklund, L | 1 |
| Buzoianu, AD; Feng, L; Huang, H; Lafuente, JV; Li, C; Lin, C; Manzhulo, I; Muresanu, DF; Nozari, A; Sharma, A; Sharma, HS; Tian, ZR; Wang, Z; Wiklund, L; Zhang, Z | 1 |
1 review(s) available for 3-n-butylphthalide and alpha-synuclein
| Article | Year |
|---|---|
Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson's Disease Following Concussi
Topics: alpha-Synuclein; Antibodies, Monoclonal; Brain Injuries, Traumatic; DNA-Binding Proteins; Humans; Mesenchymal Stem Cells; Nanowires; Neuroprotection; Neuroprotective Agents; Parkinson Disease | 2023 |
4 other study(ies) available for 3-n-butylphthalide and alpha-synuclein
| Article | Year |
|---|---|
dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Antioxidants; Apium; Benzofurans; Cell Survival; Cytoprotection; Glutathione; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Parkinson Disease, Secondary; PC12 Cells; Rats; Reactive Oxygen Species | 2010 |
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice.
Topics: alpha-Synuclein; Animals; Benzofurans; Disease Models, Animal; Dyskinesias; Gene Expression Regulation; Immunohistochemistry; Lipopolysaccharides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Neuroprotective Agents; Parkinson Disease, Secondary; Rotarod Performance Test; Substantia Nigra; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2018 |
Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
Topics: alpha-Synuclein; Animals; Apoptosis; Benzofurans; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Humans; Inflammasomes; Mice; Mitochondria; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Protein Aggregation, Pathological | 2021 |
Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress.
Topics: alpha-Synuclein; Antibodies; Brain; Humans; Neuroprotection; Parkinson Disease; Psychological Distress | 2023 |